Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6

Literals

ou:eid
- 2-s2.0-84884595239
ou:bibtex
- @article{Dorado2013,title = {Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6},journal = {Pharmacogenomics Journal},year = {2013},volume = {13},number = {5},pages = {452-455},author = {Gonz{\'a}lez-Vacarezza, N. and Abad-Santos, F. and Carcas-Sansuan, A. and Dorado, P. and Pe{\~n}as-Lled{\'o}, E. and Est{\'e}vez-Carrizo, F. and Llerena, A.}}
bibo:page_range
- 452-455
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884595239&origin=inward
bibo:issn
- 1470-269X
dcterms:title
- Use of pharmacogenetics in bioequivalence studies to reduce sample size: An example with mirtazapine and CYP2D6
ou:tipoPublicacion
- Article
bibo:doi
- 10.1038/tpj.2012.29
bibo:eissn
- 1473-1150
dcterms:contributor
- Gonzalez-Vacarezza N.; Abad-Santos F.; Carcas-Sansuan A.; Dorado P.; Penas-Lledo E.; Estevez-Carrizo F.; Llerena A.
dcterms:creator
- González-Vacarezza N.
vivo:identifier
- 2013-300
fabio:hasPublicationYear
- 2013
dcterms:publisher
- Pharmacogenomics Journal
ou:urlOrcid
- http://www.scopus.com/inward/record.url?eid=2-s2.0-84884595239&partnerID=MN8TOARS
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84884595239&origin=inward
ou:vecesCitado
- 12
bibo:volume
- 13